Latest News

8 April 2016

SpeeDx to Feature PlexPCR^® and ResistancePlus^® Tests on M. genitalium at ECCMID

Sydney, Australia (April 8, 2016) – SpeeDx Pty, Ltd. today announced that it will feature its PlexPCR® for detection of infectious...

Read More

21 March 2016

SpeeDx Announces Distribution Agreement for PlexPCR^® and ResistancePlus^® Molecular Diagnostics Products with Goffin Molecular Technologies

– Goffin’s distribution channels will allow broader availability and accessibility of SpeeDx diagnostics in the Benelux market – SYDNEY, AUSTRALIA–(March 21,...

Read More

1 December 2015

SpeeDx is featured in Austrade’s Success Stories

Austrade’s Success Stories article highlights our focus in tackling the growing threat of antimicrobial resistance using precision medicine. SpeeDx develops...

Read More

10 July 2015

SpeeDx is Featured in Genomeweb Article

Genomeweb highlights the launch of SpeeDx’ STI and antimicrobial resistance test. During the interview, Colin Denver – the Vice President...

Read More

13 August 2005

SpeeDx co-founder was interviewed by Business Insider Australia to represent the launch of Sydney City Council plan for Tech Startup

Elisa Mokany, one of the co-founders of SpeeDx, was interviewed by Business Insider Australia as a representative of entrepreneurs clustered...

Read More